Awardee OrganizationCHILDREN'S HOSP OF PHILADELPHIA
Description
Abstract Text
CHOP PEDIATRIC CENTER OF EXCELLENCE IN NEPHROLOGY ABSTRACT
We propose to establish a Pediatric Center of Excellence in Nephrology (PCEN) at the
Children’s Hospital of Philadelphia (CHOP). Our theme is to address barriers to clinical trials
implementation in children with kidney disease. As kidney disease in children is uncommon,
identification of adequate numbers of children with specific disorders and recruitment for trials is
difficult. Additionally, methods to clinically phenotype children with kidney disease in terms of
growth, development, nutritional issues, cardiovascular disease risk factors, bone and mineral
disorders often vary from study to study, and quality control is variable. Expertise in study
design and analysis is needed to achieve appropriate inferences from observational data, and to
design clinical trials, however, frequently pediatric centers in nephrology lack this expertise. We
will address these challenges through a regional and national collaboration of clinical and
translational researchers at CHOP, Johns Hopkins, and children’s hospitals participating in
PEDSnet. PEDSnet is a consortium of eight academic pediatric health centers that collectively
provide care for >4.5 million children. PEDSnet has established a common institutional review
board and has harmonized the diverse EHR systems of its participating centers to create a
standardized multi-institutional data network in order to facilitate the efficient conduct of
observational research, quality improvement and clinical trials.
The CHOP-PCEN will have three biomedical research cores; a Design and Analysis core, a
Clinical Phenotyping Core focused on CVD risk factors and Nutrition/Bone health, a Learning
Health System (LHS) Core, as well as a pilot and feasibility program and an enrichment core.
We include 2 research project proposals utilizing the cores: “Bone Quality and Vascular Health
in Adolescents with Urinary Stone Disease”, “Derivation and Validation of Imaging Biomarkers
for CKD Progression” and a third, integrated into the LHS core, “Skeletal Outcomes in Children
and Young Adults with Glomerular Disease”. The research base is comprised of 39
investigators, who are PI’s, co-investigators or collaborators on over 150 funded projects
totaling over $35 million in annual direct costs, over $12 million of this funding is in research
projects relevant to pediatric nephrology led by likely users of the core services. The PCEN will
build upon the strong foundation of clinical research at CHOP and Hopkins, as well as the
University of Penn Adult Nephrology Division and Center for Clinical Epidemiology and
Biostatistics to catalyze the design and implementation of clinical trials in children with kidney
disease.
Public Health Relevance Statement
CHOP PEDIATRIC CENTER OF EXCELLENCE IN NEPHROLOGY PROJECT NARRATIVE
We propose to establish a Pediatric Center of Excellence in Nephrology at the Children’s
Hospital of Philadelphia (CHOP) to address barriers to clinical trials implementation in children
with kidney disease. Kidney disease is a major cause of illness and death in children and
adolescents, however, there is a scant evidence base for therapies as few clinical trials have
been performed in this population. Our center will build on the remarkable research base at
CHOP, Johns Hopkins and the University of Pennsylvania to accelerate the design and
implementation of clinical trials in pediatric nephrology. Using the remarkable infrastructure of
PEDsnet, a clinical data research network of 8 leading children’s hospitals with the ability to
collect and use information from multiple data sources such as electronic health records
(EHRs), we will create a learning health system in pediatric nephrology in order to establish a
strong evidence base and the logistical framework for implementation of clinical trials in
childhood kidney disease.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
073757627
UEI
G7MQPLSUX1L4
Project Start Date
18-September-2017
Project End Date
14-September-2022
Budget Start Date
01-September-2021
Budget End Date
14-September-2022
Project Funding Information for 2021
Total Funding
$835,054
Direct Costs
$562,641
Indirect Costs
$272,413
Year
Funding IC
FY Total Cost by IC
2021
National Institute of Diabetes and Digestive and Kidney Diseases
$835,054
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P50DK114786-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P50DK114786-05
Patents
No Patents information available for 5P50DK114786-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P50DK114786-05
Clinical Studies
No Clinical Studies information available for 5P50DK114786-05
News and More
Related News Releases
No news release information available for 5P50DK114786-05
History
No Historical information available for 5P50DK114786-05
Similar Projects
No Similar Projects information available for 5P50DK114786-05